Gufic Biosciences Recommends Final Dividend of Re. 0.10 Per Share for FY 2025-26
Gufic Biosciences Limited announced that its Board of Directors, in a meeting held on May 29, 2026, recommended a Final Dividend for the Financial Year 2025-26.The Board recommended a Final Dividend amounting to 10%, translating to Re. 0.10 per Equity Share. This dividend is based on the financial year ended March 31, 2026.
The recommendation was made subject to the subsequent approval of the shareholders at the Annual General Meeting of the Company.
The details of the proposed dividend are summarized below:
| Metric | Value |
|---|---|
| Company | Gufic Biosciences Limited |
| Proposed Dividend | 10% |
| Per Share Amount | Re. 0.10/- |
| Face Value | Re. 1/- per Equity Share |
| Financial Year | 2025-26 |
The Board meeting for Gufic Biosciences Limited commenced at 7.30 p.m. and concluded at 9.05 p.m.
GUFICBIO Stock Price Movement
On Friday, Gufic Biosciences Limited shares gained 1.92% to close at ₹333.85, rising ₹6.25 from its previous closing price. The stock saw significant trading activity, settling within a range of ₹319.65 to ₹341.95 on a volume of 267,768 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.